0 XP   0   0   0

NATCO Pharma Limited
Buy, Hold or Sell?

Should you buy, hold or sell NATCO Pharma Limited?

I guess you are interested in NATCO Pharma Limited. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

Let's analyse NATCO Pharma Limited

Let's start. I'm going to help you getting a better view of NATCO Pharma Limited. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

  1. Company's Financial Health
    A deep dive into the books. How are the numbers doing? Is NATCO Pharma Limited even making a profit? Is the company skyrocketing? Or is it sinking like the Titanic. The trend is your friend.
  2. Market Valuation
    Finally, you now have an insight of how NATCO Pharma Limited is doing in the market. If the company is worth buying. The latest step is to find out how other investors value NATCO Pharma Limited. The closing price on 2023-01-27 was INR534.95 per share. Is the company over- or underpriced?
  3. Key Performance Indicators
    A total overlook on how the company is doing. Based on the (trends in) the key performance indicators.
NATCO Pharma Limited Daily Candlestick Chart
NATCO Pharma Limited Daily Candlestick Chart
Summary









1. Valuation of NATCO Pharma Limited




Current price per share

INR534.95

2. Growth of NATCO Pharma Limited




Is NATCO Pharma Limited growing?

Current yearPrevious yearGrowGrow %
How rich?$524.4m$506.9m$17.4m3.3%

How much money is NATCO Pharma Limited making?

Current yearPrevious yearGrowGrow %
Making money$20.9m$54.2m-$33.3m-159.4%
Net Profit Margin8.7%21.5%--

How much money comes from the company's main activities?

3. Financial Health of NATCO Pharma Limited




Comparing to competitors in the Pharmaceuticals industry




  Industry Rankings (Pharmaceuticals)  


Richest
#11 / 54

Most Revenue
#18 / 54

Most Profit
#18 / 54


Summary

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

1.1. Profitability of NATCO Pharma Limited.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit NATCO Pharma Limited earns for each ₹1 of revenue.

  • Above 10% is considered healthy but always compare NATCO Pharma Limited to the Pharmaceuticals industry mean.
  • A Net Profit Margin of 8.7% means that ₹0.09 for each ₹1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of NATCO Pharma Limited:

  • The MRQ is 8.7%. The company is making a profit. +1
  • The TTM is 8.7%. The company is making a profit. +1
Trends
Current periodCompared to+/- 
MRQ8.7%TTM8.7%0.0%
TTM8.7%YOY21.5%-12.7%
TTM8.7%5Y23.3%-14.6%
5Y23.3%10Y22.1%+1.2%
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ8.7%3.3%+5.4%
TTM8.7%6.9%+1.8%
YOY21.5%9.9%+11.6%
5Y23.3%6.3%+17.0%
10Y22.1%6.7%+15.4%
1.1.2. Return on Assets

Shows how efficient NATCO Pharma Limited is using its assets to generate profit.

  • Above 5% is considered healthy but always compare NATCO Pharma Limited to the Pharmaceuticals industry mean.
  • 3.3% Return on Assets means that NATCO Pharma Limited generated ₹0.03 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of NATCO Pharma Limited:

  • The MRQ is 3.3%. Using its assets, the company is less efficient in making profit.
  • The TTM is 3.3%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ3.3%TTM3.3%0.0%
TTM3.3%YOY9.2%-5.9%
TTM3.3%5Y11.3%-7.9%
5Y11.3%10Y12.3%-1.0%
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ3.3%0.8%+2.5%
TTM3.3%1.3%+2.0%
YOY9.2%1.5%+7.7%
5Y11.3%1.4%+9.9%
10Y12.3%1.4%+10.9%
1.1.3. Return on Equity

Shows how efficient NATCO Pharma Limited is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare NATCO Pharma Limited to the Pharmaceuticals industry mean.
  • 4.0% Return on Equity means NATCO Pharma Limited generated ₹0.04 for each ₹1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of NATCO Pharma Limited:

  • The MRQ is 4.0%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 4.0%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ4.0%TTM4.0%0.0%
TTM4.0%YOY10.7%-6.7%
TTM4.0%5Y13.6%-9.6%
5Y13.6%10Y15.7%-2.1%
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ4.0%1.5%+2.5%
TTM4.0%2.0%+2.0%
YOY10.7%3.0%+7.7%
5Y13.6%2.1%+11.5%
10Y15.7%2.0%+13.7%

1.2. Operating Efficiency of NATCO Pharma Limited.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient NATCO Pharma Limited is operating .

  • Measures how much profit NATCO Pharma Limited makes for each ₹1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare NATCO Pharma Limited to the Pharmaceuticals industry mean.
  • An Operating Margin of 0.0% means the company generated ₹0.00  for each ₹1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of NATCO Pharma Limited:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y24.7%-24.7%
5Y24.7%10Y22.5%+2.3%
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ--5.6%+5.6%
TTM-0.5%-0.5%
YOY-6.2%-6.2%
5Y24.7%5.1%+19.6%
10Y22.5%5.2%+17.3%
1.2.2. Operating Ratio

Measures how efficient NATCO Pharma Limited is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Pharmaceuticals industry mean).
  • An Operation Ratio of 1.21 means that the operating costs are ₹1.21 for each ₹1 in net sales.

Let's take a look of the Operating Ratio trends of NATCO Pharma Limited:

  • The MRQ is 1.215. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.215. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.215TTM1.2150.000
TTM1.215YOY1.029+0.186
TTM1.2155Y0.969+0.246
5Y0.96910Y0.874+0.094
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ1.2151.342-0.127
TTM1.2151.276-0.061
YOY1.0291.169-0.140
5Y0.9691.149-0.180
10Y0.8741.178-0.304

1.3. Liquidity of NATCO Pharma Limited.

1.3. Liquidity
1.3.1. Current Ratio

Measures if NATCO Pharma Limited is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Pharmaceuticals industry mean).
  • A Current Ratio of 3.52 means the company has ₹3.52 in assets for each ₹1 in short-term debts.

Let's take a look of the Current Ratio trends of NATCO Pharma Limited:

  • The MRQ is 3.515. The company is very able to pay all its short-term debts. +2
  • The TTM is 3.515. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ3.515TTM3.5150.000
TTM3.515YOY4.447-0.932
TTM3.5155Y3.635-0.120
5Y3.63510Y3.087+0.548
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ3.5152.205+1.310
TTM3.5152.010+1.505
YOY4.4472.125+2.322
5Y3.6351.812+1.823
10Y3.0871.786+1.301
1.3.2. Quick Ratio

Measures if NATCO Pharma Limited is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare NATCO Pharma Limited to the Pharmaceuticals industry mean.
  • A Quick Ratio of 1.86 means the company can pay off ₹1.86 for each ₹1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of NATCO Pharma Limited:

  • The MRQ is 1.861. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 1.861. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ1.861TTM1.8610.000
TTM1.861YOY2.350-0.490
TTM1.8615Y1.739+0.122
5Y1.73910Y1.468+0.270
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ1.8611.118+0.743
TTM1.8611.152+0.709
YOY2.3501.091+1.259
5Y1.7391.007+0.732
10Y1.4680.869+0.599

1.4. Solvency of NATCO Pharma Limited.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of NATCO Pharma Limited assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare NATCO Pharma Limited to Pharmaceuticals industry mean.
  • A Debt to Asset Ratio of 0.17 means that NATCO Pharma Limited assets are financed with 16.5% credit (debt) and the remaining percentage (100% - 16.5%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of NATCO Pharma Limited:

  • The MRQ is 0.165. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.165. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.165TTM0.1650.000
TTM0.165YOY0.140+0.026
TTM0.1655Y0.169-0.004
5Y0.16910Y0.203-0.034
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1650.381-0.216
TTM0.1650.379-0.214
YOY0.1400.417-0.277
5Y0.1690.398-0.229
10Y0.2030.399-0.196
1.4.2. Debt to Equity Ratio

Measures if NATCO Pharma Limited is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare NATCO Pharma Limited to the Pharmaceuticals industry mean.
  • A Debt to Equity ratio of 19.8% means that company has ₹0.20 debt for each ₹1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of NATCO Pharma Limited:

  • The MRQ is 0.198. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.198. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.198TTM0.1980.000
TTM0.198YOY0.163+0.036
TTM0.1985Y0.204-0.006
5Y0.20410Y0.261-0.058
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1980.586-0.388
TTM0.1980.598-0.400
YOY0.1630.598-0.435
5Y0.2040.671-0.467
10Y0.2610.664-0.403

2. Market Valuation of NATCO Pharma Limited

2. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every ₹1 in earnings NATCO Pharma Limited generates.

  • Above 15 is considered overpriced but always compare NATCO Pharma Limited to the Pharmaceuticals industry mean.
  • A PE ratio of 97.06 means the investor is paying ₹97.06 for every ₹1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of NATCO Pharma Limited:

  • The EOD is 57.435. Good. +1
  • The MRQ is 97.058. Neutral. Compare to industry.
  • The TTM is 97.058. Neutral. Compare to industry.
Trends
Current periodCompared to+/- 
EOD57.435MRQ97.058-39.623
MRQ97.058TTM97.0580.000
TTM97.058YOY39.778+57.280
TTM97.0585Y41.007+56.051
5Y41.00710Y32.266+8.741
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
EOD57.43540.785+16.650
MRQ97.05851.661+45.397
TTM97.05851.419+45.639
YOY39.77864.495-24.717
5Y41.00756.903-15.896
10Y32.26661.712-29.446
2.2. Price Earnings to Growth Ratio

Measures the predicted future growth of NATCO Pharma Limited.

  • Lower is better.
  • A PEG ratio of 1 means the market price of the stock and the expected future earnings are on par.

Let's take a look of the Price Earnings to Growth Ratio trends of NATCO Pharma Limited:

  • The MRQ is 251.974. Seems overpriced? -1
  • The TTM is 251.974. Seems overpriced? -1
Trends
Current periodCompared to+/- 
MRQ251.974TTM251.9740.000
TTM251.974YOY41.635+210.339
TTM251.9745Y73.145+178.829
5Y73.14510Y73.1450.000
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
MRQ251.9740.015+251.959
TTM251.9740.036+251.938
YOY41.6350.327+41.308
5Y73.1450.144+73.001
10Y73.1450.144+73.001

2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of NATCO Pharma Limited is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Pharmaceuticals industry mean).
  • A PB ratio of 3.87 means the investor is paying ₹3.87 for each ₹1 in book value.

Let's take a look of the Price to Book Ratio trends of NATCO Pharma Limited:

  • The EOD is 2.290. Good. +1
  • The MRQ is 3.870. Neutral. Compare to industry.
  • The TTM is 3.870. Neutral. Compare to industry.
Trends
Current periodCompared to+/- 
EOD2.290MRQ3.870-1.580
MRQ3.870TTM3.8700.000
TTM3.870YOY4.255-0.385
TTM3.8705Y4.065-0.195
5Y4.06510Y3.780+0.285
Compared to industry (Pharmaceuticals)
PeriodCompanyIndustry (mean)+/- 
EOD2.2902.248+0.042
MRQ3.8702.690+1.180
TTM3.8703.050+0.820
YOY4.2553.185+1.070
5Y4.0652.899+1.166
10Y3.7802.711+1.069
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of NATCO Pharma Limited compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--7.5547.5540%18.784-60%27.795-73%38.933-81%
Book Value Growth--1.0341.0340%1.092-5%1.241-17%1.247-17%
Book Value Per Share--233.596233.5960%226.042+3%204.867+14%159.851+46%
Book Value Per Share Growth--1.0331.0330%1.091-5%1.223-16%1.223-16%
Current Ratio--3.5153.5150%4.447-21%3.635-3%3.087+14%
Debt To Asset Ratio--0.1650.1650%0.140+18%0.169-2%0.203-19%
Debt To Equity Ratio--0.1980.1980%0.163+22%0.204-3%0.261-24%
Dividend Per Share--4.5044.5040%6.247-28%7.014-36%7.192-37%
Dividend Per Share Growth--0.7210.7210%0.740-3%0.937-23%0.937-23%
Eps--9.3149.3140%24.180-61%26.360-65%22.812-59%
Eps Growth--0.3850.3850%0.955-60%0.869-56%0.869-56%
Free Cash Flow Per Share---10.749-10.7490%2.424-543%1.672-743%2.030-629%
Free Cash Flow Per Share Growth---4.434-4.4340%0.752-690%0.496-994%0.496-994%
Free Cash Flow To Equity Per Share---8.843-8.8430%-7.760-12%3.761-335%3.315-367%
Free Cash Flow To Equity Per Share Growth--0.8610.8610%1.264-32%7.124-88%7.124-88%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max--904.560--------
Intrinsic Value_10Y_min--742.132--------
Intrinsic Value_1Y_max--11.135--------
Intrinsic Value_1Y_min--10.820--------
Intrinsic Value_3Y_max--94.051--------
Intrinsic Value_3Y_min--87.741--------
Intrinsic Value_5Y_max--250.020--------
Intrinsic Value_5Y_min--224.605--------
Net Profit Margin--0.0870.0870%0.215-59%0.233-63%0.221-60%
Operating Margin----0%-0%0.247-100%0.225-100%
Operating Ratio--1.2151.2150%1.029+18%0.969+25%0.874+39%
Pb Ratio2.290-69%3.8703.8700%4.255-9%4.065-5%3.780+2%
Pe Ratio57.435-69%97.05897.0580%39.778+144%41.007+137%32.266+201%
Peg Ratio--251.974251.9740%41.635+505%73.145+244%73.145+244%
Price Per Share534.950-69%904.000904.0000%961.850-6%820.110+10%751.521+20%
Price To Total Gains Ratio44.366-69%74.97274.9720%38.427+95%34.289+119%29.516+154%
Profit Growth--0.3860.3860%0.957-60%0.883-56%1.252-69%
Quick Ratio--1.8611.8610%2.350-21%1.739+7%1.468+27%
Return On Assets--0.0330.0330%0.092-64%0.113-70%0.123-73%
Return On Equity--0.0400.0400%0.107-63%0.136-71%0.157-75%
Revenue Growth--0.9480.9480%1.072-12%0.990-4%1.144-17%
Total Gains Per Share--12.05812.0580%25.031-52%34.809-65%46.125-74%
Total Gains Per Share Growth--0.4820.4820%1.010-52%0.695-31%0.695-31%
Usd Book Value--524422800.000524422800.0000%506956800.000+3%460509540.000+14%380683242.857+38%
Usd Book Value Change Per Share--0.0930.0930%0.231-60%0.342-73%0.479-81%
Usd Book Value Per Share--2.8732.8730%2.780+3%2.520+14%1.966+46%
Usd Dividend Per Share--0.0550.0550%0.077-28%0.086-36%0.088-37%
Usd Eps--0.1150.1150%0.297-61%0.324-65%0.281-59%
Usd Free Cash Flow---24132600.000-24132600.0000%5436600.000-544%3766260.000-741%2690185.714-997%
Usd Free Cash Flow Per Share---0.132-0.1320%0.030-543%0.021-743%0.025-629%
Usd Free Cash Flow To Equity Per Share---0.109-0.1090%-0.095-12%0.046-335%0.041-367%
Usd Price Per Share6.580-69%11.11911.1190%11.831-6%10.087+10%9.244+20%
Usd Profit--20910000.00020910000.0000%54230700.000-61%59342580.000-65%53687742.857-61%
Usd Revenue--239210400.000239210400.0000%252408300.000-5%251126640.000-5%234640071.429+2%
Usd Total Gains Per Share--0.1480.1480%0.308-52%0.428-65%0.567-74%
 EOD+3 -2MRQTTM+0 -0YOY+6 -355Y+9 -3310Y+10 -32

3.2. Fundamental Score

Let's check the fundamental score of NATCO Pharma Limited based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1557.435
Price to Book Ratio (EOD)Between0-12.290
Net Profit Margin (MRQ)Greater than00.087
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than11.861
Current Ratio (MRQ)Greater than13.515
Debt to Asset Ratio (MRQ)Less than10.165
Debt to Equity Ratio (MRQ)Less than10.198
Return on Equity (MRQ)Greater than0.150.040
Return on Assets (MRQ)Greater than0.050.033
Total5/10 (50.0%)

3.3. Technical Score

Let's check the technical score of NATCO Pharma Limited based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose538.850
Total1/1 (100.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2017-12-312018-12-312019-12-312020-12-312021-12-31
Other Stockholders Equity  -141,00017,000-124,00018,000-106,00063,000-43,000414,000371,000



Latest Balance Sheet

Balance Sheet of 2021-12-31. Currency in INR. All numbers in thousands.

Summary
Total Assets51,091,000
Total Liabilities8,455,000
Total Stockholder Equity42,636,000
 As reported
Total Liabilities 8,455,000
Total Stockholder Equity+ 42,636,000
Total Assets = 51,091,000

Assets

Total Assets51,091,000
Total Current Assets24,972,000
Long-term Assets24,972,000
Total Current Assets
Cash And Cash Equivalents 1,111,000
Short-term Investments 2,950,000
Net Receivables 6,206,000
Inventory 8,620,000
Other Current Assets 3,586,000
Total Current Assets  (as reported)24,972,000
Total Current Assets  (calculated)22,473,000
+/- 2,499,000
Long-term Assets
Property Plant Equipment 23,084,000
Goodwill 507,000
Intangible Assets 822,000
Long-term Assets Other 469,000
Long-term Assets  (as reported)26,119,000
Long-term Assets  (calculated)24,882,000
+/- 1,237,000

Liabilities & Shareholders' Equity

Total Current Liabilities7,104,000
Long-term Liabilities1,351,000
Total Stockholder Equity42,636,000
Total Current Liabilities
Short-term Debt 165,000
Short Long Term Debt 4,205,000
Accounts payable 1,618,000
Other Current Liabilities 369,000
Total Current Liabilities  (as reported)7,104,000
Total Current Liabilities  (calculated)6,357,000
+/- 747,000
Long-term Liabilities
Long term Debt Total 80,000
Capital Lease Obligations 115,000
Long-term Liabilities  (as reported)1,351,000
Long-term Liabilities  (calculated)195,000
+/- 1,156,000
Total Stockholder Equity
Common Stock365,000
Retained Earnings 27,822,000
Capital Surplus 14,078,000
Other Stockholders Equity 371,000
Total Stockholder Equity (as reported)42,636,000
Total Stockholder Equity (calculated)42,636,000
+/-0
Other
Capital Stock365,000
Cash and Short Term Investments 4,061,000
Common Stock Shares Outstanding 182,520
Liabilities and Stockholders Equity 51,091,000
Net Debt 3,094,000
Net Invested Capital 46,841,000
Net Working Capital 17,868,000



Balance Sheet

Currency in INR. All numbers in thousands.

 Trend2021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-31
> Total Assets 
18,217,000
23,176,000
37,151,000
43,031,000
45,878,000
47,919,000
51,091,000
51,091,00047,919,00045,878,00043,031,00037,151,00023,176,00018,217,000
   > Total Current Assets 
8,370,000
10,873,000
21,307,000
23,472,000
23,256,000
23,373,000
24,972,000
24,972,00023,373,00023,256,00023,472,00021,307,00010,873,0008,370,000
       Cash And Cash Equivalents 
0
358,000
1,837,000
283,000
198,000
258,000
1,111,000
1,111,000258,000198,000283,0001,837,000358,0000
       Short-term Investments 
0
321,000
684,000
3,977,000
715,000
3,983,000
2,950,000
2,950,0003,983,000715,0003,977,000684,000321,0000
       Net Receivables 
2,616,000
4,752,000
6,375,000
5,062,000
5,513,000
4,129,000
6,206,000
6,206,0004,129,0005,513,0005,062,0006,375,0004,752,0002,616,000
       Inventory 
3,573,000
3,489,000
4,384,000
5,908,000
6,987,000
9,104,000
8,620,000
8,620,0009,104,0006,987,0005,908,0004,384,0003,489,0003,573,000
       Other Current Assets 
1,192,000
1,660,000
7,449,000
7,088,000
8,147,000
3,899,000
3,586,000
3,586,0003,899,0008,147,0007,088,0007,449,0001,660,0001,192,000
   > Long-term Assets 
0
12,303,000
15,844,000
19,559,000
22,622,000
24,546,000
26,119,000
26,119,00024,546,00022,622,00019,559,00015,844,00012,303,0000
       Property Plant Equipment 
9,164,000
11,635,000
14,927,000
18,561,000
20,936,000
22,372,000
23,084,000
23,084,00022,372,00020,936,00018,561,00014,927,00011,635,0009,164,000
       Goodwill 
0
0
0
0
0
0
507,000
507,000000000
       Intangible Assets 
55,000
58,000
59,000
87,000
88,000
94,000
822,000
822,00094,00088,00087,00059,00058,00055,000
       Long-term Assets Other 
0
125,000
-59,000
17,000
-1,000
285,000
469,000
469,000285,000-1,00017,000-59,000125,0000
> Total Liabilities 
5,260,000
6,683,000
6,429,000
8,141,000
8,143,000
6,703,000
8,455,000
8,455,0006,703,0008,143,0008,141,0006,429,0006,683,0005,260,000
   > Total Current Liabilities 
4,931,000
6,265,000
5,920,000
7,287,000
6,853,000
5,256,000
7,104,000
7,104,0005,256,0006,853,0007,287,0005,920,0006,265,0004,931,000
       Short-term Debt 
984,000
2,216,000
1,732,000
3,863,000
3,277,000
163,000
165,000
165,000163,0003,277,0003,863,0001,732,0002,216,000984,000
       Short Long Term Debt 
0
2,216,000
1,732,000
3,863,000
3,277,000
2,821,000
4,205,000
4,205,0002,821,0003,277,0003,863,0001,732,0002,216,0000
       Accounts payable 
0
20,000
48,000
2,170,000
2,554,000
1,462,000
1,618,000
1,618,0001,462,0002,554,0002,170,00048,00020,0000
       Other Current Liabilities 
0
113,000
126,000
127,000
130,000
122,000
369,000
369,000122,000130,000127,000126,000113,0000
   > Long-term Liabilities 
0
377,000
471,000
834,000
1,178,000
1,429,000
1,351,000
1,351,0001,429,0001,178,000834,000471,000377,0000
       Long term Debt Total 
0
0
0
0
9,000
9,000
80,000
80,0009,0009,0000000
> Total Stockholder Equity
12,957,000
16,493,000
30,722,000
34,890,000
37,735,000
41,216,000
42,636,000
42,636,00041,216,00037,735,00034,890,00030,722,00016,493,00012,957,000
   Common Stock
348,000
349,000
369,000
365,000
364,000
365,000
365,000
365,000365,000364,000365,000369,000349,000348,000
   Retained Earnings 
6,554,000
10,055,000
15,288,000
20,601,000
23,748,000
26,979,000
27,822,000
27,822,00026,979,00023,748,00020,601,00015,288,00010,055,0006,554,000
   Capital Surplus 
6,112,000
6,178,000
15,206,000
14,048,000
13,729,000
13,915,000
14,078,000
14,078,00013,915,00013,729,00014,048,00015,206,0006,178,0006,112,000
   Treasury Stock0000000
   Other Stockholders Equity 
-57,000
-89,000
-141,000
-124,000
-106,000
-43,000
371,000
371,000-43,000-106,000-124,000-141,000-89,000-57,000



Balance Sheet

Currency in INR. All numbers in thousands.




Cash Flow

Currency in INR. All numbers in thousands.




Income Statement

Currency in INR. All numbers in thousands.


Latest Income Statement (annual, 2021-12-31)

Gross Profit (+$)
totalRevenue19,448,000
Cost of Revenue-6,003,000
Gross Profit13,445,00013,445,000
 
Operating Income (+$)
Gross Profit13,445,000
Operating Expense-17,625,000
Operating Income1,209,000-4,180,000
 
Operating Expense (+$)
Research Development1,769,000
Selling General Administrative8,956,000
Selling And Marketing Expenses-
Operating Expense17,625,00010,725,000
 
Net Interest Income (+$)
Interest Income363,000
Interest Expense-132,000
Net Interest Income213,000231,000
 
Pretax Income (+$)
Operating Income1,209,000
Net Interest Income213,000
Other Non-Operating Income Expenses-
Income Before Tax (EBT)2,022,0001,209,000
EBIT - interestExpense = -132,000
1,700,000
1,832,000
Interest Expense132,000
Earnings Before Interest and Taxes (ebit)-2,154,000
Earnings Before Interest and Taxes (ebitda)3,580,000
 
After tax Income (+$)
Income Before Tax2,022,000
Tax Provision-322,000
Net Income From Continuing Ops1,700,0001,700,000
Net Income1,700,000
Net Income Applicable To Common Shares1,700,000
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses-
Total Other Income/Expenses Net--213,000
 

Comments

Join the conversation.

Leave a comment

Stay informed with my latest content.

Subscribe to my newsletter and receive an email as soon as I add content to PenkeTrading.com.


By clicking Register, you agree to the General Terms and Conditions.
Penke's Market Notifications
0RYA.IL
now

I found you a Overbought RSI (Relative Strength Index) on the daily chart of 0RYA.IL.

0RYA.IL Daily Candlestick Chart
USCU.V
now

I found you a MACD Bullish Hidden Divergence on the daily chart of USCU.V.

USCU.V Daily Candlestick Chart
CNE.TO
1 minute ago

I found you a STOCH Bullish Hidden Divergence on the daily chart of CNE.TO.

CNE.TO Daily Candlestick Chart
BARU.V
2 minutes ago

I found you a MACD Bullish Hidden Divergence on the daily chart of BARU.V.

BARU.V Daily Candlestick Chart
ALVO.IC
10 minutes ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of ALVO.IC.

ALVO.IC Daily Candlestick Chart
HURA.TO
11 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of HURA.TO.

HURA.TO Daily Candlestick Chart
IGF.NASDAQ
12 minutes ago

I found you a Golden Cross on the daily chart of IGF.NASDAQ.

IGF.NASDAQ Daily Candlestick Chart
IGBH.NYSE ARC
12 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of IGBH.NYSE ARC.

IGBH.NYSE ARC Daily Candlestick Chart
IFGL.NASDAQ
12 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of IFGL.NASDAQ.

IFGL.NASDAQ Daily Candlestick Chart
IEMG.NYSE ARC
12 minutes ago

I found you a Golden Cross on the daily chart of IEMG.NYSE ARC.

IEMG.NYSE ARC Daily Candlestick Chart
IDRV.NYSE ARC
12 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of IDRV.NYSE ARC.

IDRV.NYSE ARC Daily Candlestick Chart
KESAR.BSE
14 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of KESAR.BSE.

KESAR.BSE Daily Candlestick Chart
SGAMY.PINK
15 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of SGAMY.PINK.

SGAMY.PINK Daily Candlestick Chart
RUG.V
15 minutes ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of RUG.V.

RUG.V Daily Candlestick Chart
FLRK.LSE
15 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of FLRK.LSE.

FLRK.LSE Daily Candlestick Chart
3BAB.LSE
16 minutes ago

I found you a STOCH Bullish Hidden Divergence on the daily chart of 3BAB.LSE.

3BAB.LSE Daily Candlestick Chart
IWSY.OTCQB
17 minutes ago

I found you a STOCH Bearish Hidden Divergence on the daily chart of IWSY.OTCQB.

IWSY.OTCQB Daily Candlestick Chart
HITC.PINK
17 minutes ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of HITC.PINK.

HITC.PINK Daily Candlestick Chart
ENRT.OTCQB
19 minutes ago

I found you a STOCH Bearish Reversal Divergence on the daily chart of ENRT.OTCQB.

ENRT.OTCQB Daily Candlestick Chart
SCOB.NASDAQ
19 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of SCOB.NASDAQ.

SCOB.NASDAQ Daily Candlestick Chart
MDMN.PINK
19 minutes ago

I found you a Overbought RSI (Relative Strength Index) on the daily chart of MDMN.PINK.

MDMN.PINK Daily Candlestick Chart
TRRE.PINK
19 minutes ago

I found you a RSI Bullish Reversal Divergence on the daily chart of TRRE.PINK.

TRRE.PINK Daily Candlestick Chart
EPWCF.OTCQB
19 minutes ago

I found you a STOCH Bullish Hidden Divergence on the daily chart of EPWCF.OTCQB.

EPWCF.OTCQB Daily Candlestick Chart
CSJP.MI
25 minutes ago

I found you a Golden Cross on the daily chart of CSJP.MI.

CSJP.MI Daily Candlestick Chart
EIMU.LSE
29 minutes ago

I found you a Golden Cross on the daily chart of EIMU.LSE.

EIMU.LSE Daily Candlestick Chart